Escient Pharmaceuticals Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Escient Pharmaceuticals is a biotechnology company based in San Diego, California, focused on discovering and developing therapies for neurosensory-inflammatory diseases. Its pipeline comprises novel small molecule antagonists that inhibit MRGPRX2 to treat various mast cell–driven conditions, as well as agents that inhibit MRGPRX4 to alleviate cholestatic pruritus. The company draws on extensive experience in GPCR drug discovery and development to advance candidates from early research toward clinical testing. Operating within the biotechnology research sector, Escient aims to address unmet needs at the intersection of neurosensory function and inflammatory processes.

In January 2024, Escient Pharmaceuticals was acquired by Incyte Corporation, reflecting a shift in ownership within the industry. Based in the San Diego area, the firm presents itself as a small, specialized biotech company pursuing novel therapies for mast cell–driven disorders and pruritus linked to liver and kidney disease.

Get verified Escient Pharmaceuticals emails free

Company overview Employee directory